3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression

Area of Science:

• Neuroscience
• Toxicology
• Biochemistry

Background:

• 3-nitropropionic acid (3-NPA) inhibits mitochondrial oxidative phosphorylation, selectively damaging the striatum.
• The exact mechanisms underlying 3-NPA-induced striatal neurotoxicity are not fully understood.
• Nitric oxide synthase (NOS) activity is implicated in various neuroinflammatory processes.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) in the selective striatal lesions induced by 3-NPA.
• To explore the effects of modulating NOS activity on 3-NPA neurotoxicity and associated behavioral disturbances.
• To identify inflammatory markers involved in 3-NPA-induced striatal damage.

Main Methods:

• Wistar rats were administered 3-NPA (20 mg/kg, s.c. daily for 2-3 days).
• Modulation of NOS activity was achieved using N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, or FK506.
• Behavioral assessments, immunoglobulin G (IgG) extravasation, glial fibrillary acidic protein (GFAP) immunoreaction, and inducible NOS-like (iNOS-L) immunoreactivity were evaluated.

Main Results:

• 3-NPA administration induced behavioral disturbances, striatal IgG extravasation, decreased GFAP, and iNOS-L immunoreactive cells.
• Pretreatment with L-NAME did not improve behavioral symptoms or survival but attenuated IgG extravasation and iNOS-L.
• Aminoguanidine or FK506 pretreatment improved behavioral symptoms and survival, reduced IgG extravasation and iNOS-L expression, and lessened striatal lesions.

Conclusions:

• The findings indicate that nitric oxide (NO) plays a significant role in the high vulnerability of the striatum to 3-NPA.
• Inducible nitric oxide synthase (iNOS), an inflammatory marker, is upregulated following 3-NPA exposure.
• Modulating iNOS activity with agents like aminoguanidine or FK506 offers a potential therapeutic strategy against 3-NPA-induced neurotoxicity.